Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 Rechallenge.
van der Westhuizen A, Lyle M, Graves MC, Zhu X, Wong JWH, Cornall K, Ren S, Pugliese L, Levy R, Majid A, Vilain RE, Bowden NA.
van der Westhuizen A, et al. Among authors: graves mc.
Cancer Res Commun. 2022 Aug 17;2(8):814-826. doi: 10.1158/2767-9764.CRC-22-0128. eCollection 2022 Aug.
Cancer Res Commun. 2022.
PMID: 36923309
Free PMC article.
Clinical Trial.